title: [Dutasteride (Avodart): a novel 5-alpha reductase inhibitor for treatment of benign prostate hypertrophy].
abstract: Dutasteride (Avodart), a novel dual 5-alpha reductase inhibitor is effective for the treatment of benign prostate hypertrophy, of more than 30 cc because the reduction of the level of dihydrotestosterone. By reducing prostatic volume, dutasteride improves moderate to severe symptoms and flow rate. It allows a reduction of disease progression by reducing the rate of acute urinary retention and need for surgery.
authors.affiliation: Service d'Urologie, Hôpital Erasme, Bruxelles.
authors.forename: M
authors.initials: M
authors.lastname: Vanden Bossche
authors.forename: J
authors.initials: J
authors.lastname: Sternon
mesh_terms: D001378:Azasteroids / Q000627:therapeutic use*; D042944:Cholestenone 5 alpha-Reductase / Q000037:antagonists & inhibitors*; D000068538:Dutasteride; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
chemical_list: D001378:Azasteroids; D042944:Cholestenone 5 alpha-Reductase; D000068538:Dutasteride